Cargando…
Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR)
BACKGROUND: Atezolizumab combined with bevacizumab plus platinum-based chemotherapy is a standard treatment for advanced non-squamous non-small-cell lung cancer (nsNSCLC). We aimed to determine the most effective platinum-based combination, such that future studies with atezolizumab can be conducted...
Autores principales: | Udagawa, Hibiki, Sugiyama, Eri, Harada, Toshiyuki, Atagi, Shinji, Koyama, Ryo, Watanabe, Satoshi, Nakamura, Yukiko, Harada, Daijiro, Hataji, Osamu, Tanaka, Fumihiro, Kida, Hiroshi, Satouchi, Miyako, Maeno, Ken, Inoue, Akira, Yoh, Kiyotaka, Yamane, Yuki, Urata, Yoshiko, Yoshioka, Hiroshige, Yamanaka, Takeharu, Goto, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350093/ https://www.ncbi.nlm.nih.gov/pubmed/34430347 http://dx.doi.org/10.21037/tlcr-21-240 |
Ejemplares similares
-
Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323
por: Kozuki, Toshiyuki, et al.
Publicado: (2020) -
Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer
por: Hisakane, Kakeru, et al.
Publicado: (2017) -
Immune-related Colitis Induced by the Long-term Use of Nivolumab in a Patient with Non-small Cell Lung Cancer
por: Yasuda, Yuichiro, et al.
Publicado: (2017) -
Oligoprogression in Non-Small Cell Lung Cancer
por: Harada, Daijiro, et al.
Publicado: (2021) -
Crizotinib for recurring non‐small‐cell lung cancer with EML4‐ALK fusion genes previously treated with alectinib: A phase II trial
por: Harada, Daijiro, et al.
Publicado: (2021)